{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:42:45Z","timestamp":1786984965261,"version":"build-2736575974"},"reference-count":44,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.bbadis.2022.166505","type":"journal-article","created":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T10:19:11Z","timestamp":1658571551000},"page":"166505","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["TRPC6 N338S is a gain-of-function mutant identified in patient with doxorubicin-induced cardiotoxicity"],"prefix":"10.1016","volume":"1868","author":[{"given":"Tong","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian M.","family":"Necela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hon-Chi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Norton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2022.166505_bb0005","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.jcmg.2012.11.017","article-title":"Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease","volume":"6","author":"Drafts","year":"2013","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1016\/j.bbadis.2022.166505_bb0010","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/10428194.2017.1323268","article-title":"Cardiovascular effects of the addition of nilotinib to standard therapy for acute myeloid leukemia","volume":"59","author":"Larsen","year":"2018","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bbadis.2022.166505_bb0015","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/FPC.0000000000000302","article-title":"Genome-wide association study of cardiotoxicity in the NCCTG N9831 (Alliance) adjuvant trastuzumab trial","volume":"27","author":"Serie","year":"2017","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.bbadis.2022.166505_bb0020","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3389\/fcvm.2020.00142","article-title":"Association of genetic variants at TRPC6 with chemotherapy-related heart failure","volume":"7","author":"Norton","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.bbadis.2022.166505_bb0025","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1681\/ASN.2015030318","article-title":"TRPC6 G757D loss-of-function mutation associates with FSGS","volume":"27","author":"Riehle","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbadis.2022.166505_bb0030","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.53311","article-title":"Structural basis for pharmacological modulation of the TRPC6 channel","volume":"9","author":"Bai","year":"2020","journal-title":"elife"},{"key":"10.1016\/j.bbadis.2022.166505_bb0035","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bbacli.2017.02.002","article-title":"Regulation of cardiac CACNB2 by microRNA-499: potential role in atrial fibrillation","volume":"7","author":"Ling","year":"2017","journal-title":"BBA Clin."},{"key":"10.1016\/j.bbadis.2022.166505_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2021.166247","article-title":"Changes in ion channel expression and function associated with cardiac arrhythmogenic remodeling by Sorbs2","volume":"1867","author":"Qian","year":"2021","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.bbadis.2022.166505_bb0045","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1113\/jphysiol.2005.103143","article-title":"Human TRPC6 expressed in HEK 293 cells forms non-selective cation channels with limited Ca2+ permeability","volume":"572","author":"Estacion","year":"2006","journal-title":"J. Physiol."},{"key":"10.1016\/j.bbadis.2022.166505_bb0050","doi-asserted-by":"crossref","first-page":"19013","DOI":"10.1074\/jbc.M117.786152","article-title":"Role of the endothelial caveolae microdomain in shear stress-mediated coronary vasorelaxation","volume":"292","author":"Lu","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2022.166505_bb0055","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1758-2946-3-33","article-title":"Open babel: an open chemical toolbox","volume":"3","author":"O'Boyle","year":"2011","journal-title":"J. Cheminform."},{"key":"10.1016\/j.bbadis.2022.166505_bb0060","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10822-010-9352-6","article-title":"Ligand docking and binding site analysis with PyMOL and Autodock\/Vina","volume":"24","author":"Seeliger","year":"2010","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.bbadis.2022.166505_bb0065","doi-asserted-by":"crossref","first-page":"W443","DOI":"10.1093\/nar\/gkv315","article-title":"PLIP: fully automated protein-ligand interaction profiler","volume":"43","author":"Salentin","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbadis.2022.166505_bb0070","doi-asserted-by":"crossref","first-page":"19097","DOI":"10.1074\/jbc.M414065200","article-title":"Molecular determinants of cardiac K(ATP) channel activation by epoxyeicosatrienoic acids","volume":"280","author":"Lu","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2022.166505_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107497","article-title":"TRPC channels: structure, function, regulation and recent advances in small molecular probes","volume":"209","author":"Wang","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbadis.2022.166505_bb0080","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1161\/CIRCRESAHA.110.225888","article-title":"TRPC channels as effectors of cardiac hypertrophy","volume":"108","author":"Eder","year":"2011","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbadis.2022.166505_bb0085","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.pbiomolbio.2017.06.010","article-title":"Role of TRPC3 and TRPC6 channels in the myocardial response to stretch: linking physiology and pathophysiology","volume":"130","author":"Yamaguchi","year":"2017","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"10.1016\/j.bbadis.2022.166505_bb0090","doi-asserted-by":"crossref","first-page":"7000","DOI":"10.1073\/pnas.1001825107","article-title":"TRPC channels are necessary mediators of pathologic cardiac hypertrophy","volume":"107","author":"Wu","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2022.166505_bb0095","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1172\/JCI27702","article-title":"TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling","volume":"116","author":"Kuwahara","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2022.166505_bb0100","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/ncomms2240","article-title":"Cardioprotection by Klotho through downregulation of TRPC6 channels in the mouse heart","volume":"3","author":"Xie","year":"2012","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbadis.2022.166505_bb0105","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1073\/pnas.1308963111","article-title":"Combined TRPC3 and TRPC6 blockade by selective small-molecule or genetic deletion inhibits pathological cardiac hypertrophy","volume":"111","author":"Seo","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2022.166505_bb0110","article-title":"Trpc6 promotes doxorubicin-induced cardiomyopathy in male mice with pleiotropic differences between males and females","volume":"8","author":"Norton","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.bbadis.2022.166505_bb0115","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1124\/mol.119.115725","article-title":"Insights into doxorubicin-induced cardiotoxicity: molecular mechanisms, preventive strategies, and early monitoring","volume":"96","author":"Wenningmann","year":"2019","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbadis.2022.166505_bb0120","first-page":"1041","article-title":"TRPC channels: regulation, dysregulation and contributions to chronic kidney disease","volume":"2019","author":"Dryer","year":"1865","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.bbadis.2022.166505_bb0125","doi-asserted-by":"crossref","first-page":"18887","DOI":"10.1074\/jbc.M311274200","article-title":"Regulation of TRPC6 channel activity by tyrosine phosphorylation","volume":"279","author":"Hisatsune","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2022.166505_bb0130","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1113\/jphysiol.2013.251249","article-title":"Molecular determinants for cardiovascular TRPC6 channel regulation by Ca2+\/calmodulin-dependent kinase II","volume":"591","author":"Shi","year":"2013","journal-title":"J. Physiol."},{"key":"10.1016\/j.bbadis.2022.166505_bb0135","doi-asserted-by":"crossref","first-page":"40534","DOI":"10.1074\/jbc.M110.160051","article-title":"Protein kinase C-dependent phosphorylation of transient receptor potential canonical 6 (TRPC6) on serine 448 causes channel inhibition","volume":"285","author":"Bousquet","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2022.166505_bb0140","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1161\/CIRCRESAHA.114.302614","article-title":"Hyperactive adverse mechanical stress responses in dystrophic heart are coupled to transient receptor potential canonical 6 and blocked by cGMP-protein kinase G modulation","volume":"114","author":"Seo","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbadis.2022.166505_bb0145","doi-asserted-by":"crossref","first-page":"R227","DOI":"10.1152\/ajpregu.00299.2019","article-title":"Doxorubicin-induced oxidative stress differentially regulates proteolytic signaling in cardiac and skeletal muscle","volume":"318","author":"Montalvo","year":"2020","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.bbadis.2022.166505_bb0150","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.bbr.2015.06.028","article-title":"Doxorubicin and cyclophosphamide induce cognitive dysfunction and activate the ERK and AKT signaling pathways","volume":"292","author":"Salas-Ramirez","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbadis.2022.166505_bb0155","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13058-021-01452-5","article-title":"Sublethal doxorubicin promotes migration and invasion of breast cancer cells: role of Src family non-receptor tyrosine kinases","volume":"23","author":"Mohammed","year":"2021","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.bbadis.2022.166505_bb0160","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41419-021-03614-x","article-title":"Regulated cell death pathways in doxorubicin-induced cardiotoxicity","volume":"12","author":"Christidi","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbadis.2022.166505_bb0165","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/0006-291X(87)90935-1","article-title":"Inhibition of protein kinase C by antineoplastic agents: implications for drug resistance","volume":"148","author":"Palayoor","year":"1987","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2022.166505_bb0170","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/oxfordjournals.jbchem.a123972","article-title":"Inhibitory effect of mitoxantrone on activity of protein kinase C and growth of HL60 cells","volume":"112","author":"Takeuchi","year":"1992","journal-title":"J. Biochem."},{"key":"10.1016\/j.bbadis.2022.166505_bb0175","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1124\/jpet.110.170191","article-title":"Long-acting phosphodiesterase-5 inhibitor tadalafil attenuates doxorubicin-induced cardiomyopathy without interfering with chemotherapeutic effect","volume":"334","author":"Koka","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbadis.2022.166505_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109190","article-title":"BAY60-2770 attenuates doxorubicin-induced cardiotoxicity by decreased oxidative stress and enhanced autophagy","volume":"328","author":"Zhao","year":"2020","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bbadis.2022.166505_bb0185","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1126\/science.1106215","article-title":"A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis","volume":"308","author":"Winn","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2022.166505_bb0190","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/ng1592","article-title":"TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function","volume":"37","author":"Reiser","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2022.166505_bb0195","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.bbadis.2007.03.005","article-title":"TRPC6 and FSGS: the latest TRP channelopathy","volume":"1772","author":"Mukerji","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2022.166505_bb0200","doi-asserted-by":"crossref","first-page":"C558","DOI":"10.1152\/ajpcell.00077.2008","article-title":"TRPC6 mutations associated with focal segmental glomerulosclerosis cause constitutive activation of NFAT-dependent transcription","volume":"296","author":"Schlondorff","year":"2009","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bbadis.2022.166505_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007771","article-title":"A novel TRPC6 mutation that causes childhood FSGS","volume":"4","author":"Heeringa","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2022.166505_bb0210","doi-asserted-by":"crossref","first-page":"10381","DOI":"10.1074\/jbc.RA118.003183","article-title":"Cryo-EM structure of the cytoplasmic domain of murine transient receptor potential cation channel subfamily C member 6(TRPC6)","volume":"293","author":"Azumaya","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2022.166505_bb0215","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1042\/BJ20050285","article-title":"Doxorubicin activates nuclear factor of activated T-lymphocytes and Fas ligand transcription: role of mitochondrial reactive oxygen species and calcium","volume":"389","author":"Kalivendi","year":"2005","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbadis.2022.166505_bb0220","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26010053","article-title":"Betulinic acid protects DOX-triggered cardiomyocyte hypertrophy response through the GATA-4\/calcineurin\/NFAT pathway","volume":"26","author":"Yoon","year":"2020","journal-title":"Molecules"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443922001764?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443922001764?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T05:10:21Z","timestamp":1760418621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443922001764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":44,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0925443922001764"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2022.166505","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TRPC6 N338S is a gain-of-function mutant identified in patient with doxorubicin-induced cardiotoxicity","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2022.166505","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"166505"}}